BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7769841)

  • 1. Mechanism of cytosine arabinoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals.
    Hu ZB; Yang GS; Li M; Miyamoto N; Minden MD; McCulloch EA
    Leukemia; 1995 May; 9(5):789-98. PubMed ID: 7769841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Mar; 10(3):410-6. PubMed ID: 8642855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2065-75. PubMed ID: 7807996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct evidence for the participation of bcl-2 in the regulation by retinoic acid of the Ara-C sensitivity of leukemic stem cells.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1995 Oct; 9(10):1667-73. PubMed ID: 7564507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside.
    Koistinen P; Wang C; Yang GS; Wang YF; Williams DE; Lyman SD; Minden MD; McCulloch EA
    Leukemia; 1991 Aug; 5(8):704-11. PubMed ID: 1715961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of reactive oxygen intermediates after treatment of blasts of acute myeloblastic leukemia with cytosine arabinoside: role of bcl-2.
    Hedley DW; McCulloch EA
    Leukemia; 1996 Jul; 10(7):1143-9. PubMed ID: 8683994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity.
    Yang GS; Wang C; Minden MD; McCulloch EA
    Leukemia; 1994 Dec; 8(12):2052-9. PubMed ID: 7807994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside.
    Yang GS; Wang C; Minkin S; Minden MD; McCulloch EA
    J Cell Physiol; 1991 Jul; 148(1):60-7. PubMed ID: 1860896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of schedule on regulated sensitivity of AML blasts to cytosine arabinoside.
    Yang GS; Minden MD; McCulloch EA
    Leukemia; 1993 Jul; 7(7):1012-9. PubMed ID: 7686602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of the synthesis of bcl-2 protein by growth factors.
    Hu ZB; Minden MD; McCulloch EA
    Leukemia; 1996 Dec; 10(12):1925-9. PubMed ID: 8946932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An association between mitochondrial function and all-trans retinoic acid-induced apoptosis in acute myeloblastic leukaemia cells.
    Zheng A; Mäntymaa P; Säily M; Siitonen T; Savolainen ER; Koistinen P
    Br J Haematol; 1999 Apr; 105(1):215-24. PubMed ID: 10233386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia.
    Lishner M; Curtis JE; Minkin S; McCulloch EA
    Leukemia; 1989 Nov; 3(11):784-8. PubMed ID: 2811479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor and interleukin-3 protect leukemic blast cells from ara-C toxicity.
    Koistinen P; Wang C; Curtis JE; McCulloch EA
    Leukemia; 1991 Sep; 5(9):789-95. PubMed ID: 1719308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro down-regulation of bcl-2 expression by all-trans retinoic acid in AML blasts.
    Pisani F; Del Poeta G; Aronica G; Venditti A; Caravita T; Amadori S
    Ann Hematol; 1997 Oct; 75(4):145-7. PubMed ID: 9402847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of bcl-2 in AML blasts by all-trans retinoic acid and its relationship to CD34 antigen expression.
    Bradbury DA; Aldington S; Zhu YM; Russell NH
    Br J Haematol; 1996 Sep; 94(4):671-5. PubMed ID: 8826891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for paclitaxel in the combination chemotherapy of acute myeloblastic leukaemia: preclinical cell culture studies.
    Curtis JE; Minkin S; Minden MD; McCulloch EA
    Br J Haematol; 1996 Nov; 95(2):354-63. PubMed ID: 8904892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular redox state and its relationship to the inhibition of clonal cell growth and the induction of apoptosis during all-trans retinoic acid exposure in acute myeloblastic leukemia cells.
    Mäntymaa P; Guttorm T; Siitonen T; Säily M; Savolainen ER; Levonen AL; Kinnula V; Koistinen P
    Haematologica; 2000 Mar; 85(3):238-45. PubMed ID: 10702810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.
    Lehmann S; Paul C; Törmä H
    Clin Cancer Res; 2001 Feb; 7(2):367-73. PubMed ID: 11234892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of bcl-2 with antisense oligonucleotides induces apoptosis and increases the sensitivity of AML blasts to Ara-C.
    Keith FJ; Bradbury DA; Zhu YM; Russell NH
    Leukemia; 1995 Jan; 9(1):131-8. PubMed ID: 7845007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cell culture model for the treatment of acute myeloblastic leukemia with fludarabine and cytosine arabinoside.
    Rayappa C; McCulloch EA
    Leukemia; 1993 Jul; 7(7):992-9. PubMed ID: 8321050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.